SCHEMBL20406096

SCHEMBL20406096

FC(F)c1ccc(Oc2ncncc2I)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20406284 0.82 TRPA1 (0.31) —
SCHEMBL20755016 0.77 TRPV4 (0.39) —
SCHEMBL20406316 0.75 DRD1 (0.35) —
SCHEMBL20406329 0.73 CYP2C9 (0.43) —
SCHEMBL20406276 0.73 PTPN1 (0.36) —
SCHEMBL20406228 0.73 EGFR (0.42) —
SCHEMBL20394451 0.71 KDR (0.34) —
SCHEMBL20406283 0.70 KDM4E (0.49) —
SCHEMBL20406282 0.70 SCN9A (0.31) —
SCHEMBL20406072 0.68 PDE10A (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10647675-B2 Biaryl derivative and medicine containing same KAKEN PHARMACEUTICAL CO., LTD. (JP) 2020-05-12 — — US disclosed
US-20190055199-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME KAKEN PHARMACEUTICAL CO., LTD. (JP) 2019-02-21 — — US disclosed
EP-3351533-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME Kaken Pharmaceutical Co., Ltd. (JP) 2018-07-25 — — EP disclosed
Send feedback